BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 382764)

  • 1. [Statistic evaluation of a multicentric test with halcinonide].
    Bosch Pérez AV; Cisneros Vela JL; Sarro Palau JA
    Actas Dermosifiliogr; 1979; 70(1-2):157-74. PubMed ID: 382764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical double blind test with flupamesone and halcinonide].
    Ferrandiz Arjonilla L
    Rev Clin Esp; 1978 Jun; 149(5):495-7. PubMed ID: 358318
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluocinonide vs halcinonide in atopic dermatitis. A paired comparison of two potent topical corticosteroids.
    Silverman A
    Cutis; 1979 Mar; 23(3):375-8. PubMed ID: 369775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis.
    Guenther L; Solomon AR; Voorhees JJ
    Cutis; 1981 Oct; 28(4):461-2, 464, 467. PubMed ID: 7030645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis.
    Bickers DR
    Cutis; 1984 Aug; 34(2):190-4. PubMed ID: 6383735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of halcinonide cream, 0.1 percent, in the treatment of moderate and severe dermatoses.
    Belknap BS; Dobson RL
    Cutis; 1981 Apr; 27(4):433-5. PubMed ID: 7226895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 0.1 percent halcinonide cream in the treatment of psoriasis.
    Finnerty EF
    Cutis; 1982 May; 29(5):506-11. PubMed ID: 7094637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Field study experiences with 2 new urea-corticosteroid preparations in intensive therapy of inflammatory dermatoses].
    Pflugshaupt C
    Schweiz Rundsch Med Prax; 1983 Jan; 72(4):128-33. PubMed ID: 6338492
    [No Abstract]   [Full Text] [Related]  

  • 9. [1.0 percent alcinonide ointment, a new topical corticosteroid preparation: clinico-therapeutic evaluation].
    Ponzio F; Scalese A; Spagnoli U
    Clin Ter; 1980 May; 93(3):295-309. PubMed ID: 7449343
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a new halcinonide formulation in the treatment of common dermatoses.
    Pirozzi DJ
    Cutis; 1982 Aug; 30(2):262-6. PubMed ID: 7128207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halcinonide (Halog)--another new topical steroid.
    Med Lett Drugs Ther; 1975 May; 17(11):46-7. PubMed ID: 1128441
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
    Turnbull BC
    Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a topical steroid antibiotic combination (halcinonide-neomycin-amphotericin) in the treatment of cutaneous candidiasis and inflammatory dermatoses.
    Theodoridis A; Vagena A; Sivenas C; Capetanakis J
    Curr Med Res Opin; 1979; 5(10):766-71. PubMed ID: 155507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies with Halcinonide and fluocortolone in local administration].
    Reinhard W; Weber G; Petres J
    Z Hautkr; 1974 Apr; 49(7):267-72. PubMed ID: 4275779
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of amcinonide and halcinonide 0.1% ointments in the treatment of psoriasis.
    Millikan LE; Mroczkowski TF
    Int J Dermatol; 1986 Oct; 25(8):542. PubMed ID: 3533806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acid vitamin A in dermatology].
    Ocaña Sierra J
    Actas Dermosifiliogr; 1976; 67(3-4):125-50. PubMed ID: 775896
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of halcinonide solution, 0.1 percent, in the treatment of eczematous diseases.
    Lynfield YL
    Cutis; 1983 Feb; 31(2):203-4. PubMed ID: 6219862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative clinical trials of 2 topical cortcoids].
    Martínez-Fresneda CG
    Rev Clin Esp; 1975 Jun; 137(6):557-63. PubMed ID: 1099627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the clinical use of a topical amphotericin B + halcinonide combination].
    Argenziano G; Marino E; Scotti L; Salerno V
    Clin Ter; 1988 May; 125(3):213-7. PubMed ID: 2973942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.